HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hazza Al Zahrani Selected Research

N-(3-(dimethylamino)propyl)docosanamide

8/2003Single center review of clinicopathological characterization in 77 patients with positive lupus anticoagulant antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hazza Al Zahrani Research Topics

Disease

1Thrombosis (Thrombus)
08/2003
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
08/2003

Drug/Important Bio-Agent (IBA)

1N-(3-(dimethylamino)propyl)docosanamideIBA
08/2003
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
08/2003
1Warfarin (Coumadin)FDA LinkGeneric
08/2003
1Antiphospholipid AntibodiesIBA
08/2003